Profil Disolusi Terbanding, Penetapan Kadar, dan Kualitas Fisik Tablet Atorvastatin Inovator, Generik Bernama Dagang, dan Generik
<em>Atorvastatin is one of the statins which is used as the first line therapy for hyperlipidemia. The patent of atorvastatin innovator ended in 2011. Besides the innovator brand of atorvastatin, several brand and one generic atorvastatin tablet are currently marketed in Indonesia. In this res...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Badan Penelitian dan Pengembangan Kesehatan
2015-08-01
|
Series: | Jurnal Kefarmasian Indonesia |
Subjects: | |
Online Access: | http://ejournal.litbang.kemkes.go.id/index.php/jki/article/view/4403 |
id |
doaj-3c717e12a2814c0fb71c6a07f7026348 |
---|---|
record_format |
Article |
spelling |
doaj-3c717e12a2814c0fb71c6a07f70263482020-11-24T22:21:06ZengBadan Penelitian dan Pengembangan KesehatanJurnal Kefarmasian Indonesia2085-675X2354-87702015-08-0152909710.22435/jki.v5i2.4403.90-974022Profil Disolusi Terbanding, Penetapan Kadar, dan Kualitas Fisik Tablet Atorvastatin Inovator, Generik Bernama Dagang, dan GenerikNurul Aini0Ratih Dian Saraswati1Intan Sari Octoberia2Pusat Biomedis dan Teknologi Dasar Kesehatan, Badan Penelitian dan Pengembangan Kesehatan, Kementerian KesehatanPusat Biomedis dan Teknologi Dasar Kesehatan, Badan Penelitian dan Pengembangan Kesehatan, Kementerian KesehatanPusat Biomedis dan Teknologi Dasar Kesehatan, Badan Penelitian dan Pengembangan Kesehatan, Kementerian Kesehatan<em>Atorvastatin is one of the statins which is used as the first line therapy for hyperlipidemia. The patent of atorvastatin innovator ended in 2011. Besides the innovator brand of atorvastatin, several brand and one generic atorvastatin tablet are currently marketed in Indonesia. In this research, dissolution profiles, assay and physical quality were investigated for three atorvastatin tablet samples consist of one innovator sample, two atorvastatin copy layer products (branded generic atorvastatin sample and atorvastatin generic sample). The dissolution testing were done using FDA (Food and Drug Administration) method. The result shows that the innovator and branded generic samples meet all the requirements for physical quality, meanwhile the generic sample failed to meet the disintegration test criteria. The branded generic sample has similar dissolution profile with the innovator, while the generic tablet was not similar. The assay were conducted using High Performance Liquid Chromatography (HPLC) method. The assay result of the innovator, branded generic, and generic samples respectively were 97,54%, 106,36% and 97,65% which means that all samples comply with general requirement of active pharmaceutical ingredient in tablet.</em>http://ejournal.litbang.kemkes.go.id/index.php/jki/article/view/4403Atorvastatin tabletsDissolution profileHPLCAssayPhysical quality |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nurul Aini Ratih Dian Saraswati Intan Sari Octoberia |
spellingShingle |
Nurul Aini Ratih Dian Saraswati Intan Sari Octoberia Profil Disolusi Terbanding, Penetapan Kadar, dan Kualitas Fisik Tablet Atorvastatin Inovator, Generik Bernama Dagang, dan Generik Jurnal Kefarmasian Indonesia Atorvastatin tablets Dissolution profile HPLC Assay Physical quality |
author_facet |
Nurul Aini Ratih Dian Saraswati Intan Sari Octoberia |
author_sort |
Nurul Aini |
title |
Profil Disolusi Terbanding, Penetapan Kadar, dan Kualitas Fisik Tablet Atorvastatin Inovator, Generik Bernama Dagang, dan Generik |
title_short |
Profil Disolusi Terbanding, Penetapan Kadar, dan Kualitas Fisik Tablet Atorvastatin Inovator, Generik Bernama Dagang, dan Generik |
title_full |
Profil Disolusi Terbanding, Penetapan Kadar, dan Kualitas Fisik Tablet Atorvastatin Inovator, Generik Bernama Dagang, dan Generik |
title_fullStr |
Profil Disolusi Terbanding, Penetapan Kadar, dan Kualitas Fisik Tablet Atorvastatin Inovator, Generik Bernama Dagang, dan Generik |
title_full_unstemmed |
Profil Disolusi Terbanding, Penetapan Kadar, dan Kualitas Fisik Tablet Atorvastatin Inovator, Generik Bernama Dagang, dan Generik |
title_sort |
profil disolusi terbanding, penetapan kadar, dan kualitas fisik tablet atorvastatin inovator, generik bernama dagang, dan generik |
publisher |
Badan Penelitian dan Pengembangan Kesehatan |
series |
Jurnal Kefarmasian Indonesia |
issn |
2085-675X 2354-8770 |
publishDate |
2015-08-01 |
description |
<em>Atorvastatin is one of the statins which is used as the first line therapy for hyperlipidemia. The patent of atorvastatin innovator ended in 2011. Besides the innovator brand of atorvastatin, several brand and one generic atorvastatin tablet are currently marketed in Indonesia. In this research, dissolution profiles, assay and physical quality were investigated for three atorvastatin tablet samples consist of one innovator sample, two atorvastatin copy layer products (branded generic atorvastatin sample and atorvastatin generic sample). The dissolution testing were done using FDA (Food and Drug Administration) method. The result shows that the innovator and branded generic samples meet all the requirements for physical quality, meanwhile the generic sample failed to meet the disintegration test criteria. The branded generic sample has similar dissolution profile with the innovator, while the generic tablet was not similar. The assay were conducted using High Performance Liquid Chromatography (HPLC) method. The assay result of the innovator, branded generic, and generic samples respectively were 97,54%, 106,36% and 97,65% which means that all samples comply with general requirement of active pharmaceutical ingredient in tablet.</em> |
topic |
Atorvastatin tablets Dissolution profile HPLC Assay Physical quality |
url |
http://ejournal.litbang.kemkes.go.id/index.php/jki/article/view/4403 |
work_keys_str_mv |
AT nurulaini profildisolusiterbandingpenetapankadardankualitasfisiktabletatorvastatininovatorgenerikbernamadagangdangenerik AT ratihdiansaraswati profildisolusiterbandingpenetapankadardankualitasfisiktabletatorvastatininovatorgenerikbernamadagangdangenerik AT intansarioctoberia profildisolusiterbandingpenetapankadardankualitasfisiktabletatorvastatininovatorgenerikbernamadagangdangenerik |
_version_ |
1725772193439154176 |